Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Malignant ascites as a marker of peritoneal carcinomatosis burden in patients with colorectal and gastroesophageal cancer.
Authors
Yong Xiang Gwee
Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore;
Yong Xiang Gwee , Daryl Chia , Leonardo Provenzano , Sara Lonardi , Veronica Conca , Chiara Cremolini , Wei Peng Yong , Patrick Tan , Jimmy Bok Yan So , Guowei Kim , Asim Shabbir , Johnny Ong , Filippo Pietrantonio , Raghav Sundar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 455)
DOI
10.1200/JCO.2023.41.4_suppl.455
Abstract #
455
Poster Bd #
L1
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Trajectories of body weight change and survival among mCRC patients treated with systemic therapy: Pooled analysis from the ARCAD database.
First Author: Jan Franko
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Serum angiopoietin-like protein 2 level in patients who received bevacizumab-containing chemotherapy for metastatic colorectal cancer.
First Author: Jung Hoon Kim
Poster
2023 ASCO Quality Care Symposium
Biomarker testing rates among metastatic cancer patients with receipt of anti-cancer systemic therapy: A real-world data analysis.
First Author: Stacey DaCosta Byfield
Poster
2023 ASCO Annual Meeting
A 19-protein signature to predict outcomes in a cohort of stage II and III CRC.
First Author: Rosemary Habib